GLP1R and depressive symptom measurement: Wegovy posts mentioned depression 1.6% (134/8527) of the time, while general GLP-1 RAs (42/4885), Ozempic (165/18,733), and semaglutide (151/17,146) posts discussed depression 0.9% of the time.